University
of VirginiaInnovates
For studentsFor UVA faculty & staffContact

The Nation · where the money and the mandate come from

National industry & VC

The industry partners and investors who scale UVA science.

Overview

National partners include AstraZeneca, which signed a master research collaboration with the Manning Institute in January 2026, and life-science investors such as RA Capital and Droia.

  • AstraZeneca master research collaboration, January 2026
  • Life-science investors including RA Capital and Droia

In the news

All stories
Biotechnology · January 2026
AstraZeneca signs a master research collaboration with the Manning Institute

The Paul & Diane Manning Institute of Biotechnology is already operating — a year before its doors open.

Connected across the map

Speed & ScaleManning Institute350K sq ft · 2027Speed & ScaleRivanna FuturesAstraZeneca $4.5BThe SchoolsData Scienceindustry partners pgmSpeed & ScaleC'Ville BioHub2,500+ jobsTranslationRolls-Royce UTC1 of 3 in the U.S.

More in The Nation

View layer
NIH$203M to UVA · #36NSFI-Corps → Enterprise StudioDOD · DARPA · DIUdual-use → Rivanna StationARPA-H & hard-technon-dilutive before equityNIH CTSA NetworkiTHRIV is the Virginia hubCoulter Foundation1 of 9 partners nationallyKEEN · NCI Designationcurriculum · 1 of 58 centers